UCB SA Ownership

UCBJF Stock  USD 174.00  0.00  0.00%   
UCB SA secures a total of 189.96 Million outstanding shares. UCB SA shows substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as UCB SA in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of UCB SA, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UCB SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

UCB Pink Sheet Ownership Analysis

About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.52. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. UCB SA last dividend was issued on the 29th of April 2022. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. Ucb SA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.The quote for UCB SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call JeanChristophe Tellier at 32 2 559 99 99 or visit https://www.ucb.com.

Currently Active Assets on Macroaxis

Other Information on Investing in UCB Pink Sheet

UCB SA financial ratios help investors to determine whether UCB Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.